Beam Therapeutics Inc (BEAM)
21.26
-1.28
(-5.68%)
USD |
NASDAQ |
May 10, 16:00
21.27
+0.01
(+0.05%)
After-Hours: 20:00
Beam Therapeutics Cash from Operations (Quarterly): -99.75M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -99.75M |
| December 31, 2023 | 135.07M |
| September 30, 2023 | -89.78M |
| June 30, 2023 | -84.67M |
| March 31, 2023 | -109.82M |
| December 31, 2022 | -69.19M |
| September 30, 2022 | -74.50M |
| June 30, 2022 | -52.28M |
| March 31, 2022 | 218.49M |
| December 31, 2021 | 1.83M |
| September 30, 2021 | 3.007M |
| Date | Value |
|---|---|
| June 30, 2021 | -32.53M |
| March 31, 2021 | -38.58M |
| December 31, 2020 | -24.30M |
| September 30, 2020 | -21.21M |
| June 30, 2020 | -22.84M |
| March 31, 2020 | -27.39M |
| December 31, 2019 | -17.80M |
| September 30, 2019 | -16.99M |
| June 30, 2019 | -11.35M |
| March 31, 2019 | -25.86M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-109.82M
Minimum
Mar 2023
218.49M
Maximum
Mar 2022
-21.73M
Average
-25.85M
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 1.166B |
| Moderna Inc | -989.00M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 1.351M |
| Xtant Medical Holdings Inc | -0.915M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -53.46M |
| Cash from Financing (Quarterly) | 2.897M |
| Free Cash Flow | -169.28M |
| Free Cash Flow Per Share (Quarterly) | -1.251 |
| Free Cash Flow to Equity (Quarterly) | -102.18M |
| Free Cash Flow Yield | -10.02% |